National guidelines recommend adjuvant intravesical Bacillus Calmette-Guérin (BCG) therapy for higher-risk non–muscle-invasive bladder cancer (NMIBC). Although a survival benefit has not been ...

Immune aging is increasingly recognized as a contributing factor in Alzheimer's disease. Previous observational studies have ...

BCG vaccine altered immune responses and modified amyloid-beta, study shows ...

New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine - which is ...

The Bacillus Calmette-Guérin (BCG) vaccine—which prevents tuberculosis—offers multiple beneficial effects, and it's currently a recommended therapy for non–muscle-invasive bladder cancer. In a new ...

Bacillus Calmette-Guérin (BCG) remains the only licensed vaccine against tuberculosis, eliciting a complex interplay between innate and adaptive immunity. Upon administration, live attenuated ...

Aidixi combined with BCG showed 100% clinical complete response rates at three and six months in high-risk NMIBC patients with HER2 expression. Event-free survival at six months was 100% for patients ...

The concept of using Mycobacterium for cancer treatment goes back to the 19th Century. Today, bacillus Calmette–Guerin (BCG) vaccine is a well-established treatment for human bladder cancer that is ...

Learn everything you need to know about BCG live - Bacillus Calmette- Guerin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side ...